{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:20:29Z","timestamp":1790367629645,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>People with cirrhosis of the liver are at increased risk of developing kidney dysfunction because of portal hypertension-induced splanchnic vasodilation which decreases effective arterial blood volume. This can lead to hepatorenal syndrome, which manifests clinically as ascites that is refractory to diuretics, a rise in creatinine, and hyponatremia. Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure that shunts blood directly from the portal vein to the hepatic vein, bypassing the high-pressure system of the cirrhotic liver. Among patients with diuretic-resistant ascites, TIPS decreases recurrence of ascites and improves kidney function. However, because less blood is passing through the hepatic sinusoids, postprocedure risks of TIPS, including worsening hepatic encephalopathy and liver ischemia, increase with the severity of liver disease. The model for end-stage liver disease score quantifies this risk using the international normalized ratio, bilirubin, and serum creatinine as variables and has been used to exclude high-risk patients from TIPS. The flaw in this method is that although serum creatinine can indicate worse hepatic function, it is a parameter of this composite score that may improve with TIPS. This review discusses the physiologic changes that occur after TIPS and recommends an individualized approach to TIPS selection in patients with kidney disease.<\/jats:p>","DOI":"10.34067\/kid.0000001011","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:01:52Z","timestamp":1758902512000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Re-Evaluating Transjugular Intrahepatic Portosystemic Shunt Candidacy for Patients with Kidney Disease"],"prefix":"10.34067","volume":"7","author":[{"given":"Megan M.","family":"Griffin","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4102-7969","authenticated-orcid":false,"given":"Cary H.","family":"Paine","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4808-910X","authenticated-orcid":false,"given":"Sarah F.","family":"Sanghavi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington"},{"name":"VA Puget Sound Healthcare System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"9615","key":"B1-20260129","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet."},{"issue":"2","key":"B2-20260129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000462974","article-title":"Molecular mechanisms leading to splanchnic vasodilation in liver cirrhosis","volume":"54","author":"Pascoli","year":"2017","journal-title":"J Vasc Res."},{"issue":"9","key":"B3-20260129","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J Clin Invest."},{"issue":"8","key":"B4-20260129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"N Engl J Med."},{"issue":"11","key":"B5-20260129","doi-asserted-by":"crossref","first-page":"e13301","DOI":"10.14814\/phy2.13301","article-title":"Hepatic vein pressure predicts GFR in cirrhotic patients with hemodynamic kidney dysfunction","volume":"5","author":"Desai","year":"2017","journal-title":"Physiol Rep."},{"issue":"3","key":"B6-20260129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(87)90442-6","article-title":"Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function","volume":"82","author":"Cade","year":"1987","journal-title":"Am J Med."},{"issue":"3","key":"B7-20260129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl."},{"issue":"3","key":"B8-20260129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cld.1031","article-title":"Hepatic venous pressure gradient","volume":"17","author":"Bochnakova","year":"2021","journal-title":"Clin Liver Dis."},{"issue":"2","key":"B9-20260129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology."},{"issue":"5","key":"B10-20260129","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2024.05.033","article-title":"Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD","volume":"81","author":"Paternostro","year":"2024","journal-title":"J Hepatol."},{"issue":"3","key":"B11-20260129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B12-20260129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology."},{"issue":"1","key":"B13-20260129","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/HEP.0000000000000530","article-title":"AASLD practice guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology."},{"issue":"3","key":"B14-20260129","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/gast.1997.v112.pm9041252","article-title":"The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt","volume":"112","author":"Wong","year":"1997","journal-title":"Gastroenterology."},{"issue":"2","key":"B15-20260129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology."},{"issue":"1","key":"B16-20260129","doi-asserted-by":"crossref","first-page":"003","DOI":"10.1055\/s-2008-1040318","article-title":"Portal hypertension and gastrointestinal bleeding","volume":"28","author":"Bosch","year":"2008","journal-title":"Semin Liver Dis."},{"issue":"25","key":"B17-20260129","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garc\u00eda-Pag\u00e1n","year":"2010","journal-title":"N Engl J Med."},{"issue":"3","key":"B18-20260129","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HEP.0000000000000613","article-title":"Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis","volume":"79","author":"Nicoar\u0103-Farc\u0103u","year":"2024","journal-title":"Hepatology."},{"issue":"2","key":"B19-20260129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: results of a randomized study","volume":"126","author":"Bureau","year":"2004","journal-title":"Gastroenterology."},{"issue":"4","key":"B20-20260129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/HEP.0000000000001091","article-title":"Predictors of long-term clinical outcomes after TIPS: an ALTA group study","volume":"81","author":"Nobel","year":"2025","journal-title":"Hepatology."},{"issue":"1","key":"B21-20260129","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.23383","article-title":"The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009","volume":"51","author":"Boyer","year":"2010","journal-title":"Hepatology."},{"issue":"2","key":"B22-20260129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut."},{"issue":"54","key":"B23-20260129","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology."},{"issue":"3","key":"B24-20260129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1477-2574.2009.00040.x","article-title":"Renal haemodynamics and function following partial portal decompression","volume":"11","author":"Ross","year":"2009","journal-title":"HPB (Oxford)."},{"issue":"12","key":"B25-20260129","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/MEG.0b013e32832ec16a","article-title":"Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis","volume":"21","author":"Appenrodt","year":"2009","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"1","key":"B26-20260129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology."},{"issue":"9053","key":"B27-20260129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet."},{"issue":"1","key":"B28-20260129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhep.2025.01.029","article-title":"EASL clinical practice guidelines on TIPS","volume":"83","author":"Bureau","year":"2025","journal-title":"J Hepatol."},{"issue":"1","key":"B29-20260129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13063-023-07261-9","article-title":"Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis\u2014a randomized controlled trial","volume":"24","author":"Ripoll","year":"2023","journal-title":"Trials."},{"issue":"2 Pt 1","key":"B30-20260129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1051-0443(07)61932-0","article-title":"Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis","volume":"13","author":"Rajan","year":"2002","journal-title":"J Vasc Interv Radiol."},{"issue":"1","key":"B31-20260129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0016-5085(00)70422-7","article-title":"Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting","volume":"118","author":"Chalasani","year":"2000","journal-title":"Gastroenterology."},{"issue":"4","key":"B32-20260129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-8278(01)00309-9","article-title":"MELD score is better than child\u2013pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt","volume":"36","author":"Salerno","year":"2002","journal-title":"J Hepatol."},{"issue":"2","key":"B33-20260129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/poh2.28","article-title":"A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement","volume":"1","author":"Yang","year":"2022","journal-title":"Portal Hypertens Cirrhosis."},{"issue":"6","key":"B34-20260129","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"Meld 3.0: the model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology."},{"issue":"1","key":"B35-20260129","first-page":"38","article-title":"MELD or MELD-Na as a predictive model for mortality following transjugular intrahepatic portosystemic shunt placement","volume":"11","author":"Krishnan","year":"2023","journal-title":"J Clin Transl Hepatol."},{"issue":"23","key":"B36-20260129","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"R\u00f6ssle","year":"2000","journal-title":"N Engl J Med."},{"issue":"11","key":"B37-20260129","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s10620-020-06136-2","article-title":"Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients","volume":"65","author":"Charilaou","year":"2020","journal-title":"Dig Dis Sci."},{"issue":"10","key":"B38-20260129","doi-asserted-by":"crossref","first-page":"e0237","DOI":"10.1097\/HC9.0000000000000237","article-title":"Use and outcome of TIPS in hospitalized patients in Germany: a Nationwide Study (2007\u20132018)","volume":"7","author":"Gu","year":"2023","journal-title":"Hepatol Commun."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:33Z","timestamp":1786478613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001011","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}